CompletedNCT05846815
Web-based ARVO tool to assess possible ADHD symptoms
About this title
Read the official source — NCT05846815Device studyAges 8–13Finland
Understand this study
Who was this study for?
Listed age limits: 8 years to 13 years.
- Listed locations
- EspooSee all locations and recruitment
Study information
Study start dateStarted: November 6, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 134
- Sponsor
- Peili Vision Ltd.
- Sponsor type
- Other organization
- Study type
- Device
- Intervention type
- DEVICE, OTHER
- Study phase
- Not clearly listed
- Locations
- Finland
- Age range
- From 8 Years to 13 Years
- Official registry ID
- NCT05846815
- Official title
Show the full official title
Assessment of ARVO Web-based Software for Evaluating Attention-Deficit/Hyperactive Disorder (ADHD) Symptoms in Children. Prospective, Controlled Clinical Investigation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Espoo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Peili Vision Ltd.
Who was this study for?
Listed age limits: 8 years to 13 years.
Want to explore more studies?
Explore studiesRelated studies
Atomoxetine or placebo to maintain response in adult ADHD
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) i...